Head and Neck Cancer Trial, Recruiting NCT04185974 Sponsor: University Hospital Heidelberg Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT04185974
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose head and neck cancer has come back or grown in the same area after they previously received radiation treatment
  • People who still have some cancer cells remaining (either visible or microscopic) after surgery to remove the tumour
  • People whose doctors have determined that a second course of radiation treatment is appropriate
  • People whose surgical wound has fully healed before starting the trial
  • People who have a Karnofsky Performance Score of 60 or higher, meaning they are able to care for themselves and carry out some normal activities (confirm with trial site)
  • People aged 18 years or older
  • People who have given written consent to participate before enrolling
  • People who are able to understand what the trial involves and what it means for them personally
  • Women who could become pregnant, and men, must be using adequate contraception during the trial
  • People who are able to provide records from their previous radiation treatment

Who may not be able to join:

  • People whose cancer requiring re-irradiation is located in the voice box (larynx)
  • People diagnosed with plasmocytoma, sarcoma, or chordoma (specific tumour types)
  • People who have already received a second course of radiation to the same area
  • People where less than 6 months has passed since their first radiation treatment
  • People who have cancer that has spread to distant parts of the body, except for the lungs
  • People who have not yet recovered from side effects caused by previous cancer treatments
  • Pregnant or breastfeeding women
  • People who have had another cancer diagnosed within the last 5 years that requires treatment that would interfere with this trial (not including certain early-stage or skin cancers, as specified by the trial site)
  • People who are currently participating in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 49 622156

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Heidelberg
Registry
ClinicalTrials.gov
Start date
25 August 2020
Est. completion
30 July 2030

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

safety of carbon ion re-irradiation; toxicity of carbon ion re-irradiation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov